The impact of the COVID-19 pandemic on the trend of prescribing long-acting injections of paliperidone and risperidone in Central Serbia
Article in Frontiers in Psychiatry (December 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia.
Article in Journal of Managed Care & Specialty Pharmacy (August 2023)
Paliperidone palmitate intramuscular 6-monthly formulation in schizophrenia: a profile of its use
Article in Drugs & Therapy Perspectives (July 2022)